Compounds > dydrogesterone
Page last updated: 2024-08-20

dydrogesterone and endothelin-1

dydrogesterone has been researched along with endothelin-1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emeis, JJ; Kenemans, P; Mijatovic, V; Schalkwijk, CG; Stehouwer, CD; van Baal, WM; van der Mooren, MJ; Vischer, UM1
Fini, M; Gambacciani, M; Genazzani, AR; Monteleone, P; Rosano, GM; Silvestri, A; Vitale, C1
de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ1

Trials

3 trial(s) available for dydrogesterone and endothelin-1

ArticleYear
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
    Fertility and sterility, 1999, Volume: 71, Issue:4

    Topics: Dydrogesterone; E-Selectin; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Postmenopause; Prospective Studies; Solubility; Thrombomodulin; von Willebrand Factor

1999
Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.
    Maturitas, 2002, Oct-25, Volume: 43, Issue:2

    Topics: Cross-Over Studies; Double-Blind Method; Dydrogesterone; Endothelin-1; Endothelium, Vascular; Estradiol; Female; Humans; Middle Aged; Premenopause; Progesterone Congeners; Vasodilation

2002
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 142, Issue:2

    Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator

2009